In accordance with the literature, not only are all leukocytes capable of producing TNF, but different tumor cells, including CML cells, also produce it, leading to increased systemic levels of TNF that are typically observed in patients with chronic myeloid leukemia [33]. This evidence concerns the gene TNF and chronic myelogenous leukemia, BCR-ABL1 positive.